BridgeBio Pharma Cash Flow Statement (2018-2026) | BBIO

Cash Flow Statement Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-174.56M-180.57M-194.27M-100.50M-146.52M-145.13M-147.91M-166.62M-174.21M-202.30M-35.00M-75.54M-164.25M-267.39M-122.26M-183.76M-184.94M-194.59M-120.03M-155.89M
Share-based Compensation (Quarter)
16.13M25.84M0.97M0.06M18.66M22.58M0.19M0.12M27.23M30.83M0.54M21.45M27.13M1.40M25.88M37.34M31.66M-84.16M4.07M44.07M
Gains from Investment Securities (Quarter)
-0.66M0.74M0.85M10.22M0.06M0.12M-0.11M-0.11M0.27M-1.04M
Asset Writedowns and Impairment (Quarter)
-3.30M12.65M0.07M
Cash from Operations (Quarter)
-121.56M-133.90M-160.63M-30.45M-135.16M-93.24M-144.32M-113.35M-145.23M-124.82M-219.54M74.70M-180.57M-195.33M-199.24M-80.68M-109.57M-56.42M-197.28M-71.10M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
1.39M1.75M2.48M1.90M2.09M2.10M2.34M2.24M2.14M2.18M2.02M1.67M1.72M10.36M25.64M27.46M
Amortization of Deferred Charges (Quarter)
0.49M2.06M0.99M0.49M1.96M1.82M1.93M
Depreciation & Amortization (CF) (Quarter)
0.27M1.53M1.88M1.58M1.65M1.66M1.63M1.64M1.64M1.58M1.60M1.57M1.54M1.37M1.28M1.32M1.40M1.44M1.19M1.05M
Change in Working Capital
Change in Receivables (Quarter)
233.74M-234.83M-0.18M4.24M110.54M-38.40M39.65M22.93M65.78M49.26M
Change in Inventory (Quarter)
3.19M13.39M6.77M1.95M7.05M21.11M
Change in Account Payables (Quarter)
-11.66M1.47M-1.81M-1.28M1.36M1.38M-3.80M-0.30M0.69M6.18M-5.93M14.79M-3.60M-3.75M17.57M-1.05M-7.43M17.52M-7.17M-1.86M
Change in Accured Expenses (Quarter)
-4.23M15.79M-2.88M10.67M-6.54M-3.60M-6.37M-4.70M6.92M11.96M-1.26M-7.12M1.77M23.60M2.94M-18.58M18.85M74.60M4.62M89.88M
Other Working Capital Changes (Quarter)
5.14M-3.74M-7.90M-0.79M-1.40M2.42M0.48M-3.67M-1.28M-0.97M24.02M-17.52M14.07M1.30M0.49M-0.31M17.35M-18.64M1.79M1.38M
Investing Activities
Capital Expenditures (Quarter)
-1.80M10.80M0.75M2.51M-3.20M4.76M0.01M0.43M-0.25M-0.09M0.69M-0.62M0.20M0.01M0.01M1.08M0.07M0.44M
Sales of Property, Plant and Equipment (Quarter)
10.00M
Divestments (Quarter)
29.41M25.68M2.30M
Change in Acquisitions & Divestments (Quarter)
-234.19M375.46M6.67M3.04M443.11M26.87M18.00M23.55M39.41M29.59M63.23M31.77M10.00M29.60M
Cash from Investing Activities (Quarter)
58.97M21.80M138.62M149.70M146.86M17.96M12.30M4.12M37.68M-0.07M22.75M3.04M38.23M-3.24M-1.59M-13.00M4.46M-14.35M-42.73M17.89M
Financing Activities
Other financing activities (Quarter)
2.17M-3.82M1.12M-1.12M2.56M0.19M1.62M1.59M-4.20M0.54M0.24M0.03M-0.81M0.80M2.44M11.29M-12.37M5.47M5.22M
Cash from Financing Activities (Quarter)
-135.46M325.38M-0.16M-20.80M1.45M6.38M150.25M-1.23M307.04M-4.52M279.55M-5.73M0.71M473.93M60.33M302.04M-0.89M-2.18M549.89M-148.77M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
4.90M143.02M1.03M241.30M-0.45M315.25M38.16M-0.02M
Dividend Payments
Dividends Paid - Common (Quarter)
Additional items
Change in Cash (Quarter)
-198.05M213.29M-22.17M98.45M13.14M-68.90M18.23M-110.47M199.50M-129.41M82.76M72.01M-141.63M275.37M-140.50M208.36M-106.00M-72.96M309.88M-201.98M
Free Cash Flow (Quarter)
-119.76M-144.69M-161.38M-32.96M-131.96M-98.00M-144.33M-113.78M-144.98M-124.73M-220.23M75.33M-180.77M-195.33M-199.24M-80.68M-109.59M-57.51M-197.35M-71.54M
Net Cash Flow (Quarter)
-198.05M213.29M-22.17M98.45M13.14M-68.90M18.23M-110.47M199.50M-129.41M82.76M72.01M-141.63M275.37M-140.50M208.36M-106.00M-72.96M309.88M-201.98M